Lexaria Bioscience (LEXX) Profit After Tax Growth (3y) (2020 - 2026)
Lexaria Bioscience (LEXX) Profit After Tax Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
33.21% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
30.60% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-154.28% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
16.53% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Lexaria Bioscience |
7.49 Mn |
1.97 Mn |
20,000.00 |
-3.82% |
| Date | Value |
|---|
| Feb 28, 2026 |
-3.82% |
| Nov 30, 2025 |
3.15% |
| Aug 31, 2025 |
-19.45% |
| May 31, 2025 |
-16.15% |
| Feb 28, 2025 |
-23.98% |
| Nov 30, 2024 |
-10.70% |
| Aug 31, 2024 |
-23.11% |
| May 31, 2024 |
11.46% |
| Feb 29, 2024 |
-54.00% |
| Nov 30, 2023 |
-18.42% |
| Aug 31, 2023 |
-34.45% |
| May 31, 2023 |
-19.12% |
| Feb 28, 2023 |
-6.93% |
| Nov 30, 2022 |
-21.62% |
| Aug 31, 2022 |
-30.48% |
| May 31, 2022 |
-26.74% |
| Feb 28, 2022 |
-7.33% |
| Nov 30, 2021 |
-41.64% |
| Aug 31, 2021 |
1.35% |
| May 31, 2021 |
9.17% |
